Searchable abstracts of presentations at key conferences in endocrinology

ea0032p189 | Cardiovascular Endocrinology & Lipid Metabolism | ECE2013

Metabolic profile of transsexual persons on cross-sex hormonal therapy in a multi-center prospective intervention study

Van Caenegem Eva , Wierckx Katrien , Taes Youri , Kaufman Jean-Marc , Schreiner Thomas , T'Sjoen Guy

Introduction: Gender differences in insulin resistance, body composition and lipid profile are well known and related to sex steroid hormones. In this study, we examine the metabolic profile of transsexual persons undergoing drastic sex steroid changes, during the first year of hormonal therapy.Design: This research is part of a prospective intervention study conducted in several European gender teams (Ghent, Oslo, Amsterdam, and Florence).<p class="...

ea0032p682 | Neuroendocrinology | ECE2013

Hormonal therapy satisfaction is associated with better quality of life in transsexual persons

Wierckx Katrien , Geerts Lieselot , Anseeuw Edward , Motmans Joz , Elaut Els , Heylens Gunter , Decuypere Griet , T'Sjoen Guy

Introduction: Quality of life in transsexual persons after transition is among the most important outcome factors.Methods: A specialist center cross-sectional study in 193 transsexual women and 128 transsexual men (mean age 42.5 years) after on average 7.4 years of cross-sex hormone therapy and 6.6 years since sex reassignment surgery (SRS), compared to an age-and gender matched control population (1 to 3 matching). Self-reported physical and mental heal...

ea0032p969 | Steroid metabolism and action | ECE2013

Cross-sex hormone therapy related adverse events: data from a large gender identity unit

Wierckx Katrien , Anseeuw Edward , Geerts Lieselot , Elaut Els , Heylens Gunter , Motmans Joz , Decuypere Griet , T'Sjoen Guy

Introduction: Hormonal therapy is part of an established treatment of gender identity disorder, however outcome data regarding mortality and morbidity are scant.Methods: A specialist center cross-sectional study in 193 transsexual women and 128 transsexual men (mean age 42.5 years) assessing physical health and incidence of possible treatment related adverse events compared to an age-matched female and male control group recruited from a population study...